Bumper Offer - Urjas oil Just @ Rs. 1
Niftas 50 Tablet is a prescription medicine that is available as a Tablet. Urinary Tract Infection are some of its major therapeutic uses. Other than this, Niftas 50 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Niftas 50 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Niftas 50 Tablet as well, which are listed below. These side effects of Niftas 50 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Niftas 50 Tablet's effect is Safe during pregnancy and Moderate for lactating mothers. It is important to know if Niftas 50 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Niftas 50 Tablet related warnings section.
Niftas 50 Tablet is contraindicated in people with pre-existing medical conditions like Kidney Disease, Anemia, Liver Disease as it can result in adverse effects. Some other conditions that can be affected by Niftas 50 Tablet are listed in the contraindications section below.
Drug interactions for Niftas 50 Tablet have been reported in the medical literature. See below for a complete list.
You should also be aware that Niftas 50 Tablet is not safe while driving, and is not addiction.
Niftas 50 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Niftas 50 Tablet is used -
Severe
Moderate
Mild
Is the use of Niftas 50 Tablet safe for pregnant women?
Pregnant women can take Niftas without worrying about any side effects.
Is the use of Niftas 50 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Niftas. If you see any side effects, stop taking Niftas immediately and talk to your doctor. Take Niftas again, only after your doctor's advice.
What is the effect of Niftas 50 Tablet on the Kidneys?
Niftas may have mild side effects on the kidneys.
What is the effect of Niftas 50 Tablet on the Liver?
Niftas may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Niftas 50 Tablet on the Heart?
Niftas may have mild side effects on the heart. Most people will never see any effect on the heart.
Niftas 50 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Niftas 50 Tablet unless your doctor advises you to do so -
Is this Niftas 50 Tablet habit forming or addictive?
Forming a habit of Niftas 50 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Niftas 50 Tablet as you may feel sleepy.
Is it safe?
Niftas 50 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Niftas 50 Tablet is not used to treat mental disorders.
Interaction between Food and Niftas 50 Tablet
Taking Niftas 50 Tablet with food does not cause any problems.
Interaction between Alcohol and Niftas 50 Tablet
Consuming limited amounts of alcohol while taking Niftas 50 Tablet does not cause any harmful effects. But it is best to observe caution.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
